Literature DB >> 16508900

Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.

G Winterer1.   

Abstract

Strong evidence exists for disturbed functional connectivity of cortical microcircuits--particularly of prefrontal cortex. Dopamine, long implicated in antipsychotic drug effects, is crucially involved in optimizing signal-to-noise ratio of local cortical micro-circuits. This action of dopamine is achieved by means of D1- and D2-receptor-mediated effects on pyramidal and local circuit neurons, which mediate recurrent inhibition and thus contribute to the stability of cortical representations of external and internal stimuli. In schizophrenia, a diminished cortical dopamine D1/D2 activation ratio--in concert with altered GABAergic and glutamatergic transmission--appear to critically interfere with this process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508900     DOI: 10.1055/s-2006-931498

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  13 in total

Review 1.  Toward a neurobiology of delusions.

Authors:  P R Corlett; J R Taylor; X-J Wang; P C Fletcher; J H Krystal
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

2.  Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.

Authors:  L V Kristiansen; B Bakir; V Haroutunian; J H Meador-Woodruff
Journal:  Schizophr Res       Date:  2010-03-29       Impact factor: 4.939

Review 3.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 4.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

5.  Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.

Authors:  Monika Paul-Samojedny; Malgorzata Kowalczyk; Renata Suchanek; Aleksander Owczarek; Anna Fila-Danilow; Aleksandra Szczygiel; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2010-09       Impact factor: 3.444

6.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Authors:  Sumie Leung; Rodney J Croft; Valérie Guille; Kirsty Scholes; Barry V O'Neill; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

7.  Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study.

Authors:  Peter J Siekmeier; David P vanMaanen
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

8.  GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.

Authors:  Aurora Arrúe; Ricardo Dávila; Mercedes Zumárraga; Nieves Basterreche; Miguel A González-Torres; Biotza Goienetxea; Maria I Zamalloa; Juan B Anguiano; José Guimón
Journal:  Neurochem Res       Date:  2009-08-22       Impact factor: 3.996

9.  Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Authors:  Jiajun Shi; Elliot S Gershon; Chunyu Liu
Journal:  Schizophr Res       Date:  2008-08-20       Impact factor: 4.939

10.  Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions.

Authors:  P R Corlett; G K Murray; G D Honey; M R F Aitken; D R Shanks; T W Robbins; E T Bullmore; A Dickinson; P C Fletcher
Journal:  Brain       Date:  2007-08-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.